Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4 Stomatitis 3 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Cancer Pain 2 Thromboembolism 1 Successful Conversion Rate of Operation 1 Sarcoma 1 Respiratory Insufficiency 1 Prostatic Neoplasms 1 Pneumonia 1 Pancreatic Neoplasms 1 Pain 1 Myocardial Infarction 1 Multiple Myeloma 1 Mucositis 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Kidney Diseases 1 Hematologic Neoplasms 1 Arrhythmias, Cardiac 1 Angina, Unstable 1 Adenocarcinoma 1 Acute Coronary Syndrome 1

Interventions

Docetaxel 277 Prednisone 236 enzalutamide 175 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 153 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 78 abiraterone 75 gallium 68 PSMA-11 74 Specimen Handling 67 Gonadotropin-Releasing Hormone 58 darolutamide 56 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 49 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Sodium Bicarbonate × Clear all

NCT06661902 2026-02-17

BURN

University of Washington

Phase 1/2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡